Argos Therapeutics' Arcelis™ Immunotherapy for the Treatment of Renal Cell ... - PR Newswire (press release) PDF Print
PR Newswire (press release)
DURHAM, NC, June 1, 2011 /PRNewswire/ -- Argos Therapeutics announced today that its Arcelis™ immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib demonstrated a strong immunologic response that ...
Argos Therapeutics' Arcelis™ Immunotherapy for the Treatment of Renal Cell

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.